Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Suzuken Co ( (JP:9987) ).
Suzuken Co., Ltd. reported that it repurchased 370,700 of its common shares on the Tokyo Stock Exchange during December 2025 for a total of approximately ¥2.27 billion, as part of an ongoing share buyback program authorized under Japan’s Companies Act. Cumulatively, under the buyback framework approved in May 2025, the company has acquired 3,575,600 shares for about ¥20.39 billion as of December 30, 2025, moving significantly toward its ceiling of 5.2 million shares or ¥26 billion and signaling continued emphasis on shareholder returns and capital efficiency.
The most recent analyst rating on (JP:9987) stock is a Buy with a Yen6800.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. is a Japan-based company listed on the Prime Markets of the Tokyo and Nagoya stock exchanges and the Sapporo Securities Exchange. The company operates in the healthcare and pharmaceutical distribution sector, focusing on supplying medicines and related products across Japan’s medical and drugstore channels.
Average Trading Volume: 168,952
Technical Sentiment Signal: Buy
Current Market Cap: Yen348B
For detailed information about 9987 stock, go to TipRanks’ Stock Analysis page.